TRENA LAWSON: Open Payments
NPI 1891734711 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,329 in 231 payments from 19 companies in 2025. Trend: 2023 $2,614 · 2024 $3,107 · 2025 $4,329
Food & beverage: $4,329
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 26 | $605 |
| Alkermes, Inc. | 20 | $451 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $407 |
| Otsuka America Pharmaceutical, Inc. | 29 | $362 |
| Corium, LLC | 15 | $323 |
| ABBVIE INC. | 15 | $287 |
| Axsome Therapeutics, Inc. | 14 | $259 |
| Vanda Pharmaceuticals Inc. | 12 | $243 |
| Supernus Pharmaceuticals, Inc. | 8 | $190 |
| Teva Pharmaceuticals USA, Inc. | 8 | $165 |
Products named: INGREZZA, REXULTI, CAPLYTA, LYBALVI, Azstarys, VRAYLAR, FANAPT, Qelbree.
Industry payments across TN — which companies pay providers there.
